Profile

Introduction

Committed to developing and manufacturing high-end intraocular lenses and providing every cataract patient with high quality products and services globally.

Simedice Biotechnologies, Inc. uses its state-of-art technologies to develop, manufacture and market hydrophobic acrylic intraocular lens products, and dedicates to helping global cataract patients see brilliantly.

Simedice offers series of premium products through its innovative optical designs and proprietary high-precision manufacturing processes, which enable Simedice Lenses to own precise optical properties and the tightest manufacturing tolerance (±0.15 OD) for reduced variability to improve surgical predictability. Simedice has been building up a comprehensive Quality Management System under ISO 13485 standard and implementing very strict quality control practice to ensure that every lens made by Simedice has the highest quality.

Simedice monofocal and toric intraocular lenses are currently available globally. The multifocal, EDOF and multifocal toric intraocular lenses are still under development and will be available soon.

Introduction

Our Culture

  • Innovation
  • progress
  • cooperation
  • care

Advocate the quality policy of "Technology Innovation, Quality First, Forge Ahead, and Sustainable Development", and strive to become a global leading manufacturer offering high-end ophthamic medical devices.

Our Team

Our Team

Simedice owns a seasoned core technical team in research & development, manufacturing and quality management with more than 100 years accumulated experience from the leading multinational intraocular lens companies.

The key managers have worked overseas in management positions in global 500 multinational biotechnology companies for more than ten years, or demostically in technical leadership positions in publicly listed pharmaceutical high-tech companies for more than ten years.



Key Milestones

Global Partners

  • 3
  • 2
  • 1